Cadrenal Therapeutics Inc... (CVKD)
NASDAQ: CVKD
· Real-Time Price · USD
12.60
-0.32 (-2.48%)
At close: Aug 15, 2025, 3:59 PM
12.68
0.63%
After-hours: Aug 15, 2025, 04:10 PM EDT
-2.48% (1D)
| Bid | 11.88 |
| Market Cap | 25.79M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -8.99M |
| EPS (ttm) | -8.88 |
| PE Ratio (ttm) | -1.42 |
| Forward PE | -2.45 |
| Analyst | Buy |
| Ask | 12.68 |
| Volume | 29,026 |
| Avg. Volume (20D) | 28,753 |
| Open | 13.00 |
| Previous Close | 12.92 |
| Day's Range | 12.07 - 13.00 |
| 52-Week Range | 5.70 - 22.90 |
| Beta | 0.96 |
About CVKD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CVKD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CVKD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+23.72%
Cadrenal Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
9 months ago
+17.97%
Cadrenal Therapeutics shares are trading higher after the company announced that is has raised gross proceeds of approximately $5.1 million through its at-the-market facility.
